Record Details

CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Economic Times dated 20th December 2022

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/16551/
https://health.economictimes.indiatimes.com/news/industry/cmfri-signs-mou-to-launch-product-from-seaweeds-to-combat-fatty-liver-disease/96374281
 
Title CMFRI signs MoU to launch product from
seaweeds to combat fatty liver disease The Economic Times dated 20th December 2022
 
Creator CMFRI, Library
 
Subject CMFRI News Clippings
 
Description CMFRI has signed an MoU with a private company dealing with health products for commercial production and marketing Cadalmin LivCure extract. A unique blend of 100% natural bioactive ingredients extracted from select seaweeds, the product is made using eco-friendly technology to improve liver health. It is the ninth nutraceutical developed by the CMFRI.
 
Publisher The Economic Times
 
Date 2022
 
Type Article
PeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/16551/1/The%20Economic%20Times_20-12-2022.pdf
CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Economic Times dated 20th December 2022. The Economic Times.